Keith D. Combrink

Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

Christopher Cianci, Kuo‐Long Yu, Keith D. Combrink et al. · Antimicrobial Agents and Chemotherapy · 2004 · 135 citations · Full text

Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection

Christopher Cianci, Eugene V. Genovesi, Lucinda Lamb et al. · Antimicrobial Agents and Chemotherapy · 2004 · 77 citations · Full text

Immunology, Oral Efficacy, Antiviral Drug +16

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Kuo‐Long Yu, Ny Sin, Rita L. Civiello et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 68 citations

Oral Bioavailability, Medicine, Antiviral Drug Development +6

Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Paul M. Scola, Alan Xiangdong Wang, Andrew C. Good et al. · Journal of Medicinal Chemistry · 2014 · 66 citations · Full text

Formal 2 + 2 and 3 + 2 cycloaddition reactions of 2H-chromenes with 2-alkoxy-1,4-benzoquinones: regioselective synthesis of substituted pterocarpans

Thomas A. Engler, Jayachandra P. Reddy, Keith D. Combrink et al. · The Journal of Organic Chemistry · 1990 · 61 citations

Cycloaddition Reactions, Diversity Oriented Synthesis, Derivatives +12